You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 149 No. 1, January 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hydrochlorothiazide Is Not Additive to Verapamil in Treating Essential Hypertension

John P. Nicholson, MD; Lawrence M. Resnick, MD; John H. Laragh, MD

Arch Intern Med. 1989;149(1):125-128.


Abstract



• Calcium channel blockers, a newer class of antihypertensive medications, have gained considerable acceptance as monotherapeutic agents, particularly in low renin hypertension where diuretics are also most effective. To study whether thiazide diuretics exert an additional antihypertensive effect in the setting of calcium channel blockade, we gave verapamil hydrochloride (360 mg/d) or hydrochlorothiazide (25 mg/d) alone and in combination in an open study to 13 hypertensive patients with mild to moderate essential hypertension. Both verapamil and hydrochlorothiazide lowered blood pressure (170±17/109±6 mm Hg pretreatment to 150±25/95±8 mm Hg with verapamil; 170±5/109±2 mm Hg pretreatment to 164±25/103±10 mm Hg with hydrochlorothiazide), but addition of hydrochlorothiazide to verapamil resulted in no added benefit (150±25/95±8 mm Hg vs 150±20/95±6 mm Hg). Furthermore, while hydrochlorothiazide lowered serum potassium values (4.2±0.25 mmol/L to 3.7±0.35 mmol/L) and stimulated plasma renin activity (1.5±1.3 ng/mL/h pretreatment to 3.3 ±2.7 ng/mL/h with verapamil), verapamil only modestly elevated renin activity (1.5 ± 1.3 ng/mL/h pretreatment to 2.7 ±2.5 ng/mL/h with verapamil) and did not lower potassium values. Altogether, the data suggest that in essential hypertension, at least for verapamil, concurrent diuretic therapy may not be helpful or warranted.

(Arch Intern Med 1989;149:125-128)



Author Affiliations



From the Cardiovascular Center, The New York Hospital—Cornell Medical Center, New York.


Footnotes



Accepted for publication July 21, 1988.

Read in part before the American Society of Hypertension, New York, May 19, 1987.

Reprint requests to Cardiovascular Center, The New York Hospital—Cornell Medical Center, 525 E 68th St, Starr-4, New York, NY 10021 (Dr Nicholson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension
Townsend and Holland
Arch Intern Med 1990;150:1175-1183.
ABSTRACT  

Calcium Entry Blockers in the Treatment of Hypertension: Current Status and Future Prospects
Kaplan
JAMA 1989;262:817-823.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.